Skip to main content
PARK MEDI WORLD LIMITED logo

PARK MEDI WORLD LIMITED — Investor Relations & Filings

Ticker · PARKHOSPS ISIN · INE119201023 LEI · 335800BM62WGSJ4M6N94 BSE.NS Human health and social work activities
Open in API
Filings indexed 108 across all filing types
Latest filing 2026-03-02 Regulatory Filings
Country IN India
Listing BSE.NS PARKHOSPS

About PARK MEDI WORLD LIMITED

https://www.parkhospital.in

Park Medi World Limited operates as a healthcare provider, primarily known for its network of multi-specialty hospitals. The organization focuses on delivering a wide range of medical services, including advanced surgical procedures, diagnostic imaging, and specialized treatments in fields such as cardiology, oncology, neurology, and orthopedics. Equipped with modern medical infrastructure and technology, the company provides accessible and comprehensive healthcare solutions. Its service portfolio encompasses inpatient and outpatient care, emergency services, and intensive care units, supported by a team of experienced medical professionals and support staff. The company emphasizes clinical excellence and patient-centric care across its various facilities, integrating modern therapeutic approaches with diagnostic precision.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, -Meeting with Analysts/Investors
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It announces the company's participation in an investor conference organized by Arihant Capital, specifying the date, event, and mode of meeting. There is no financial data, report content, or detailed presentation included. The document is short (1730 characters) and serves as an announcement of an upcoming investor meeting rather than the meeting materials or transcript itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-03-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It announces a scheduled meeting of company management with investors/analysts at an upcoming conference. The content is an announcement of an event involving investor relations, not a financial report, earnings release, or detailed presentation. The document is short (1730 characters) and serves as a notification rather than containing substantive financial data or analysis. It does not fit categories like Earnings Release, Investor Presentation, or Interim Report. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings under listing regulations.
2026-03-02 English
Update on the Acquisition
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing an update on an acquisition. It references previous announcements and provides updated timelines for completing the acquisition of shares in a target company. The content is an update on financing and capital structure changes related to acquisition activities, not a full report or financial statement. The document length is 3296 characters, which is relatively short and focused on acquisition update information. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2026-02-26 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing an update on the acquisition timeline of a company. It references previous announcements and provides details about the acquisition process and timelines. The document is an update announcement related to a capital transaction (acquisition) rather than the full acquisition agreement or merger filing itself. It does not contain financial statements or detailed merger documents but is an update on financing/capital activity. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 3296 characters, which is relatively short and consistent with an announcement rather than a full report.
2026-02-26 English
Monitoring Agency Report
Audit Report / Information Classification · 95% confidence The document is a Monitoring Agency Report for the quarter ended December 31, 2025, related to the utilization of IPO proceeds by Park Medi World Limited. It is issued pursuant to SEBI regulations and includes detailed financial data on the use of funds raised through the IPO, including amounts utilized, sources of information, and certifications. The report is comprehensive, contains substantive financial data and analysis, and is not merely an announcement or certification. It is a regulatory-required monitoring report on IPO proceeds utilization, which fits best under the category of Audit Report / Information (AR), as it is a standalone report related to financial monitoring and compliance, not a full annual or quarterly report, nor a simple announcement or presentation. Q3 2026
2026-02-13 English
Monitoring Agency Report for the Quarter ended December 31, 2025
Regulatory Filings Classification · 95% confidence The document is a Monitoring Agency Report issued by CRISIL Ratings Limited for the quarter ended December 31, 2025, concerning the utilization of IPO proceeds by Park Medi World Limited. It references specific regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI ICDR Regulations, 2018. The report includes detailed financial data on the use of IPO funds, certifications by statutory auditors, and comments on the progress of the objects funded by the IPO proceeds. The document is substantive, contains financial and operational details, and is not merely an announcement or certification. This type of report is a regulatory compliance report related to IPO proceeds monitoring, which fits best under the category of Regulatory Filings (RNS) as it does not match other more specific categories like Annual Report, Interim Report, or Capital/Financing Update. It is a compliance disclosure under SEBI regulations rather than a financial report or earnings release.
2026-02-13 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.